.png)
LifeSci Continuum with Bill Schick
I'm a Fractional Chief Marketing Officer for life science companies and I help them accelerate product adoption & make marketing work.
This is LifeSci Continuum, where we explore the unbroken sequence of innovation, strategy, & growth in the life sciences industry. Join us as we explore the insights and experiences of founders, product managers, commercialization leaders, & marketing pros in the field.
Discover the strategies & tactics that have worked for them, hear about their challenges and triumphs, and gain valuable knowledge to help your company thrive.
From commercialization to full life cycle product management and marketing, learn about the latest trends in pharmaceutical, biotech, med device and healthcare marketing, product management, and branding.
From groundbreaking startups to exit-stage brands, we uncover the secrets to success in the life sciences, reflecting the ongoing evolution that defines our industry.
As a fractional CMO in the life sciences, I can help you establish, track, and optimize the right metrics and KPIs that align with your business objectives. This includes defining what success looks like for your specific stage of growth, whether it's early lead generation, nurturing prospects, or moving toward commercialization. I'll ensure that your marketing efforts are measured using data-driven insights, helping to identify opportunities, optimize campaigns, and make informed decisions to accelerate growth and ROI while minimizing wasteful efforts.
For more specialized help with growth, check out my firm, Mesh.
https://meshagency.com/
LifeSci Continuum with Bill Schick
How (and Why) to Maintain a Customer-Centric Focus When Planning Your Exit | Glenn Hanner
Follow Bill: https://www.linkedin.com/in/founderandcdo/
Contact Bill: https://meshagency.com/lets-connect/
Follow Glenn: https://www.linkedin.com/in/glenn-hanner-632291a/
Video Podcast: https://www.youtube.com/@BillSchickFCMO
Audio Podcast: https://www.buzzsprout.com/2380430
In this episode of LifeSci Continuum, I'm thrilled to reconnect with Glenn Hanner as we dig into a critical challenge that many life science leaders face: the danger of tunnel vision when planning for an exit. Often, the excitement of an exit strategy can overshadow the need to establish a strong foundation and deliver on the promised value to customers. Glenn and I pull from our experiences to discuss how companies can balance long-term strategic goals with immediate customer-centric needs to avoid costly oversights.
Glenn and I explore how companies can get so fixated on the endgame that they neglect the foundational work necessary for sustainable growth, from quality assurance to customer satisfaction. Glenn shares examples from his career, illustrating how failing to invest in fundamentals can derail even the best-laid plans for an IPO or acquisition. This episode is a must-listen for life science professionals aiming to build lasting value, not just chase short-term wins.
For more specialized help with growth, check out my firm, Mesh.
https://meshagency.com/
#LifeSciences #HealthcareInnovation #ProductMarketing
00:00 Intro
01:45 Examples of Investors Affecting a Life Science Company’s Exit Strategy
04:40 Mistakes Caused By Rushing an Exit
06:37 Regulatory Oversight in Med Tech
08:25 Example of a Med Tech Product that was Rushed to Market
09:58 Lessons & Regrets from a Med Tech Marketing Associate
12:34 The Most Important Asset for a Med Tech Start Up Company
13:52 Delivering on the Value Proposition
14:14 Life Science Career Mistakes & Regrets
15:20 Examples of a Good Exit Strategy
17:00 The Ins & Outs of Life Science Regulation
18:56 The Value of Good Leadership
20:35 Why Marketing Function is Different in Every Industry
22:05 Alignment Between Marketing & Business Goals
24:42 A Book that Every Marker Should Read - Positioning by Al Ries & Jack Trout
25:24 Psychology & Bad Landing Pages
26:07 Storytelling
26:55 Your Customer’s Needs